Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
Thomas Kurt Eigentler
Charité - Universitätsmedizin Berlin
Learn more about SSRN Profiles
SCHOLARLY PAPERS
1
DOWNLOADS
86
TOTAL CITATIONS
0
Feedback
Scholarly Papers (1)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
Nomogram for Predicting Survival after First-Line Anti-Pd-1 Immunotherapy in Unresectable Stage IV Melanoma: A Multicenter International Study
Number of pages: 29
Posted: 21 Dec 2023
Eftychia Chatziioannou
,
Lina Maria Serna-Higuita
,
Sophia Kreft
,
Lidija Kandolf
,
Branko Dujoivc
,
Lydia Reinhardt
,
Etterlin Tamara
,
Ivan Márquez-Rodas
,
Ana Raquel Ferraz Pereira Fortuna
,
Alica Nübling
,
Heike Niessner
,
Andrea Forschner
,
Claus Garbe
,
Aleksandar Popovic
,
Balic Mirjana
,
Friedegund Meier
, Thomas Kurt Eigentler,
Ulrike Leiter
,
Lukas Flatz
,
Tobias Sinnberg
and
Teresa Amaral
University of Tübingen, University of Tübingen, Charité - Universitätsmedizin Berlin, Military Medical Academy of Belgrade, Military Medical Academy of Belgrade, Dresden University of Technology, Kantonsspital St Gallen, Hospital Universitario Gregorio Marañón, Centro Hospitalar e Universitário do Algarve, University of Tübingen, University of Tübingen, University of Tübingen, University of Tübingen - Centre for Dermatooncology, University Clinical Centre of Serbia, University Clinical Centre of Serbia, Dresden University of Technology, Charité - Universitätsmedizin Berlin, University of Tübingen, University of Tübingen, University of Tübingen and University of Tübingen - Centre for Dermatooncology
Downloads
86
(765,566)
View PDF
Download
Abstract:
nomogram, melanoma, survival, checkpoint inhibitors, anti-PD-1, first line, stage IV
Feedback